We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Inverted Research Microscopes Technology Developed for Bioimaging

By LabMedica International staff writers
Posted on 30 Oct 2012
Two new inverted research microscopes have been developed, one for ultraviolet (UV)-visible imaging and the other for visible-infrared (IR) imaging for multiphoton microscopy.

The new technology directly tackles the difficulty of focus drift, which decreases the effectiveness of acquired data, specifically in long-term time-lapse observations using higher magnifications and resolutions. More...
The new Perfect Focus systems (PFS) address this issue by keeping the focus precise and making corrections on a millisecond time-scale due to Nikon’s proprietary optical offset technique.

Nikon Instruments, Inc. (Melville, NY, USA), a developer of optical instruments, recently released the third-generation Perfect Focus systems. The new models of the TI-ND6-PFS-S Perfect Focus unit have been optimized for UV-Visible imaging and Visible-IR Imaging for multiphoton microscopy.

“For biological and medical researchers, the new Perfect Focus systems are critical to support high-end life science experiments,” said Stephen Ross, PhD, general manager of product and marketing at Nikon Instruments. “Whether you are studying the microstructure of cell interiors with systems like our N-STORM Super Resolution microscope, analyzing the activity in deep layers of brain as you can with multi-photon microscopy, or time-lapse imaging of iPS [induced pluripotent stem] cell differentiation patterns, Perfect Focus has become an essential tool to ensure successful experiments.”

Features of the new PFS systems include enable easier access to objective lenses and their correction collars. Moreover, all PFS functions are now controlled through the personal computer (PC) or external controller, eliminating the need to open and close environmental chambers, which can lead to disturbances in the imaging temperature.

The new PFS systems can correct for axial drifts and sustain focus at larger distances from the objective, for example, deeper depths in the imaging specimen. This new capability is not only applicable for developmental biology, but other fields of research as research trends move toward studying the dynamics of cells in their natural environment such as thick tissues or whole animals.

The multiphoton model of the new PFS now provides compatibility with a larger range of imaging wavelengths, increasing the capabilities of fluorophores and lasers that can be used for multiphoton imaging and other near-infrared applications such as optical trapping/tweezers. The new MP PFS can correct for focus drifts even when imaging with wavelengths ranging from 880-1,300 nm.

The plastic dish, which is less costly and suitable for cell culture, in addition to glass bottom dishes, can be used with the PFS systems. Use of plastic dishes allows researchers to reduce running costs and simplify workflow, particularly helpful for high-throughput screening applications that involve multiwell plates.

The Perfect Focus technology will be presented at the Society for Neuroscience meeting in New Orleans (LA, USA), October 13-17, 2012, and will be available in December 2012.

Related Links:

Nikon Instruments




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.